VRTX Form 144: Proposed sales and recent dispositions

VRTX reported proposed sales and recent dispositions in a Form 144 submission.

Rhea-AI Filing Summary

VRTX reported proposed sales and recent dispositions in a Form 144 submission. The filing lists two restricted stock vesting events (1,020 shares on 02/17/2026 and 954 shares on 02/24/2026) and four reported sales by Carmen R. Bozic between 03/13/2026 and 05/15/2026.

Key Figures

Restricted stock vesting: 1,020 shares Restricted stock vesting: 954 shares Sale: 2,329 shares +3 more

6 metrics

Restricted stock vesting 1,020 shares vested on 02/17/2026 (compensation)

Restricted stock vesting 954 shares vested on 02/24/2026 (compensation)

Sale 2,329 shares sold on 03/13/2026 for $1,122,088.91

Sale 2,329 shares sold on 03/27/2026 for $1,050,262.55

Sale 6,988 shares sold on 05/12/2026 for $3,144,600.00

Sale 1,354 shares sold on 05/15/2026 for $613,971.30

Key Terms

Rule 144 / Form 144, Restricted Stock Vesting, Issuer

3 terms

Rule 144 / Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Restricted Stock Vesting financial

"Common | 02/17/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer regulatory

"Restricted Stock Vesting | Issuer | | | 1020"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VRTX's Form 144 disclose about recent sales?

The filing discloses four dispositions by Carmen R. Bozic between 03/13/2026 and 05/15/2026. These include specific share counts and proceeds for each trade, listed individually in the submission.

How many restricted shares vested according to the VRTX filing?

Two restricted stock vesting events are reported: 1,020 shares vested on 02/17/2026 and 954 shares vested on 02/24/2026. Each is labeled as compensation in the filing.

What were the proceeds reported for the largest sale listed in the filing?

The largest reported proceeds were $3,144,600.00 from a sale of 6,988 shares on 05/12/2026. Each sale shows share count, date, and gross proceeds in the submission.

Who is the reporting person in the Form 144 and what address is listed?

The filing shows Carmen R. Bozic as the reporting person with an address at 50 Northern Avenue, Boston MA 02210. That name is tied to the four sales detailed in the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 01:31 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001790029
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Bozic Carmen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1974	888300.00	253805417	05/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			1020	02/17/2026	Compensation
Common	02/24/2026	Restricted Stock Vesting	Issuer			954	02/24/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/13/2026	2329	1122088.91
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/27/2026	2329	1050262.55
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/12/2026	6988	3144600.00
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/15/2026	1354	613971.30

144: Remarks and Signature

Remarks
Date of Notice	05/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carmen Bozic
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)